Tirzepatide Tizaro – 10mg / 12.5mg / 15mg (Prefilled Syringe) – (ZISKA Pharma)

ZISKA Pharma Tirzepatide Tizaro – 10mg / 12.5mg / 15mg (Prefilled Syringe)

Tizaro Tirzepatide by ZISKA Pharma is a pharmaceutical-grade dual GIP/GLP-1 receptor agonist, designed for individuals seeking powerful appetite suppression, enhanced satiety, and metabolic balance.

Tirzepatide targets two key metabolic pathways:

🔹 GLP-1 pathway

• Supports appetite reduction

• Promotes slower gastric emptying

• Helps improve glucose control

🔹 GIP pathway

• Enhances insulin sensitivity

• Supports metabolic function

• Enhances satiety and fullness

Because it activates both GIP and GLP-1 receptors simultaneously, Tirzepatide is recognized as more potent than single-pathway GLP-1 analogues like Semaglutide.

ZISKA Pharma’s Tizaro comes in a prefilled syringe format, ensuring clean dosing, convenience, and consistent pharmaceutical quality.

Available Strengths:

• 10mg – strong foundational support

• 12.5mg – intermediate/high potency

• 15mg – maximum-strength option for advanced use

Each dose is manufactured under strict pharmaceutical standards for purity, sterility, and reliability.

Key Benefits

•  Dual-agonist (GIP + GLP-1) for superior appetite suppression
•  Stronger metabolic impact compared to Semaglutide
•  Helps reduce cravings and overeating
•  Increases feelings of fullness after meals
•  Supports improved metabolic balance
•  Comes in convenient prefilled syringes
•  ZISKA Pharma pharmaceutical-grade production